Microcolonies: a novel morphological form of pathogenic Mycoplasma spp

Rakovskaya, I. V.; Ermolaeva, S. A.; Levina, G. A.; Barkhatova, O. I.; Mukhachev, A. Y.; Andrievskaya, S. G.; Zhukhovitsky, V. G.; Gorina, L. G.; Miller, G. G.; Sysolyatina, E. V.

doi:10.1101/535559

bioRxiv · 10.1101/535559

Microcolonies: a novel morphological form of pathogenic Mycoplasma spp

Rakovskaya, I. V.·Ermolaeva, S. A.·Levina, G. A.·Barkhatova, O. I.·Mukhachev, A. Y.·Andrievskaya, S. G.·Zhukhovitsky, V. G.·Gorina, L. G.·Miller, G. G.·Sysolyatina, E. V.

View original source ↗Export metadata ↓

Abstract

The work describes a novel morphological form found in 5 species of Mollicutes: Mycoplasma hominis, M. fermentans, M. gallisepticum, M. pneumoniae, Acholeplasma laidlawii. The form, which is referred to as microcolonies (MCs) in contrast to typical colonies (TCs), was characterized by tiny propeller-shaped colonies formed by rod-like cells tightly packed in parallel rows. MCs were observed within routinely cultivated type strain cultures of the listed species, and rod-like cells could be seen ewith SEM within TCs of the "fried-egg" type. Pure MC cultures were obtained by treatment of Mycoplasma cultures with hyperimmune serum, antibiotics or argon non-thermal plasma. Appearance of MCs was observed 7-12 days post plating while TCs appeared 24-48 h post plating. MCs derived from the M. hominis type strain H-34 were characterized in details. MCs did not differ from the parental culture in the MLST, direct fluorescent and epifluorescent tests and Western-blotting with a monospecific camel-derived nanoantibody aMh-FcG2a. Meanwhile, MCs derived from this strain and other listed species were resistant to at least 9 antibiotics and did not hydrolyze arginine and/or glucose in standard bacteriological tests. MC cultures that belonged to M. hominis (n=70), M. pneumoniae (n=2), M. fermentans (n=2), Mycoplasma spp (n=5) were isolated from clinical samples of serum, synovial liquid and urina of patients with inflammatory urogenital tract diseases, asthma, arthritis. The reported MCs might be similar to "small colony variants" (SCVs) described in other bacterial species. However, in contrast to SCVs, MCs have never reverted to TCs. Multiple consecutive re-plating steps (for up to 3 years) were not sufficient to provide appearance of TCs within a pure MC culture. An unknown role of MCs in infection pathology along with their prominent antibiotic resistance makes them a challenge for the future studies of Mollicutes. Author summaryHere we demonstrated that Mycoplasma species form small size colonies (referred to as minicolonies, MCs). MC size is ten times less than the size of typical Mycoplasma colonies (TCs). MCs are very slow growing: it was required 9-10 days for MCs to form in contrast to 24-72 h required for TCs to form. The presents a system of evidences that MCs are formed by the same species as TCs, which they have been obtained from. Pure culture of MCs might be obtained from TC cultures by treatment with the hyperimmune serum, antibiotic and non-thermal gas plasma. MCs of all species were resistant to antibiotics effective against TCs. MCs did not hydrolyze arginine and glucose in standard bacteriological tests. MCs of different Mycoplasma species were isolated from clinical samples of sera, urea and synovial fluids from patients with urolithiasis, rheumatoid arthritis and asthma. MCs never have reverted to TCs even after three years passing. A role of MCs in infectious pathology has not been established yet. Nevertheless, ability to persist in the human body and extreme antibiotic resistance make MCs to be a challenge for the future research.

Source connections

Published article ↗

Explore related subjects

microbiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Rakovskaya, I. V., Ermolaeva, S. A., Levina, G. A., Barkhatova, O. I., Mukhachev, A. Y., Andrievskaya, S. G., Zhukhovitsky, V. G., Gorina, L. G., Miller, G. G., Sysolyatina, E. V.. 2019-01-31. Microcolonies: a novel morphological form of pathogenic Mycoplasma spp. https://doi.org/10.1101/535559

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗